Pancreatic Cancer Action Network Calls for Urgently Needed Research and Funding for Effective Early Detection Strategy and ...

Pancreatic cancer survivor Pranathi Perati talks about the importance of clinical trials for patients facing this tough ...

Recent advances in pancreatic cancer detection are offering hope, with new techniques and technologies aiming to identify the ...

Cancer diagnoses are expected to exceed two million in 2025, with approximately 618,120 deaths predicted, according to the ...

Silexion Therapeutics' SIL-204 exhibits synergy with key pancreatic cancer drugs in preclinical studies. Phase 2/3 trials ...

Although long considered a disease of aging, certain cancers are turning up more often in younger women, according to a new report.

A new report from the American Cancer Society shows that cancer mortality rates continue to decline, but diagnoses are on the ...

Silexion Therapeutics (SLXN) announced new preclinical results demonstrating the synergistic efficacy of its proprietary second-generation ...

Cancer deaths overall are falling, but the burden is shifting toward younger adults and women, the American Cancer Society ...

Cancer researchers found that patients on GLP-1s had significant risk reductions for 10 of 13 obesity-associated cancers.

An experimental blood test for pancreatic cancer is being evaluated by a commercial laboratory, an important milestone toward ...

Though cancer mortality overall is dropping, the burden of disease is shifting to women and younger adults, American Cancer ...